Danli Kong, Zhenhua Mai, Yongze Chen, Ling Luo, Hao Liu, Le Zhao, . . . Yuanlin Ding. (2022). ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation. MDPI AG.
Chicago Style (17th ed.) CitationDanli Kong, et al. ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation. MDPI AG, 2022.
MLA (9th ed.) CitationDanli Kong, et al. ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.